2022 is a year full of changes and uncertainties in the international arena. In February, Russia launched an invasion of Ukraine, and the war has been raging on since then. Besides, as the global pandemic is gradually easing, countries are gradually progressing towards a return to normal. Apart from the Russo-Ukrainian war and the COVID-19 pandemic, there are a number of significant events that have shaken the global biotech and pharmaceutical industry throughout this year. As 2022 draws to a close, explore GeneOnline's round-up of industry news stories that dominated the year.

1. How Did the Russian Invasion of Ukraine Affect Global Biopharma?